Conference Coverage: SABCS 2023

Expert perspectives and strategic insights on the latest therapeutic developments in breast cancer treatment

December 12, 2023


Adam Brufsky, MD, PhD

University of Pittsburgh School of Medicine, PA, USA

Faculty Members

Mark Pegram, MD
Stanford University School of Medicine, Stanford, CA, USA

Joyce A. O’Shaughnessy, MD
Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, TX, USA

William Sikov, MD, FACP, FNCBC
Women & Infants Hospital of Rhode Island, Providence, RI, USA

Guy Jerusalem, MD, PhD
Sart-Tillman University Hospital, Liège, Belgium

Giuseppe Curigliano, MD, PhD
Istituto Europeo di Oncologia, Milan, Italy

Javier Cortes, MD, PhD
Vall d’Hebron University Hospital, Barcelona, Spain

Sample Report

Start discovering the insights

View Report


  • New and Emerging Treatments in HER2+ Early and Metastatic BC
  • New and Emerging Approaches in HR+, HER2– Early BC
  • New and Emerging Approaches in HR+, HER2– Metastatic BC
  • Advances in Early and Metastatic Triple-Negative Breast Cancer (TNBC)

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.